TCR Activation Eliminates Glutamate Receptor GluR3 from the Cell Surface of Normal Human T Cells, via an Autocrine/Paracrine Granzyme B-Mediated Proteolytic Cleavage

Abstract

The majority of resting normal human T cells, like neuronal cells, express functional receptors for glutamate (the major excitatory neurotransmitter in the CNS) of the ionotropic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-receptor subtype 3 (GluR3). Glutamate by itself (∼10 nM) activates key T cell functions, including adhesion to fibronectin and laminin and chemotactic migration toward CXCL12/stromal cell-derived factor 1. In this study, we found by GluR3-specific immunostaining, flow cytometry, and Western blots that GluR3 cell surface expression decreases dramatically following TCR activation of human T cells. CXCR4, VLA-4, and VLA-6 also decrease substantially, whereas CD147 increases as expected, after TCR activation. Media of TCR-activated cells “eliminates” intact GluR3 (but not CXCR4 and VLA-6) from the cell surface of resting T cells, suggesting GluR3 cleavage by a soluble factor. We found that this factor is granzyme B (GB), a serine protease released by TCR-activated cells, because the extent of GluR3 elimination correlated with the active GB levels, and because three highly specific GB inhibitors blocked GluR3 down-regulation. Media of TCR-activated cells, presumably containing cleaved GluR3B peptide (GluR3 aa 372–388), inhibited the specific binding of anti-GluR3B mAb to synthetic GluR3B peptide. In parallel to losing intact GluR3, TCR-activated cells lost glutamate-induced adhesion to laminin. Taken together, our study shows that “classical immunological” TCR activation, via autocrine/paracrine GB, down-regulates substantially the expression of specific neurotransmitter receptors. Accordingly, glutamate T cell neuroimmune interactions are influenced by the T cell activation state, and glutamate, via AMPA-GluR3, may activate only resting, but not TCR-activated, T cells. Finally, the cleavage and release to the extracellular milieu of the GluR3B peptide may in principle increase its antigenicity, and thus the production, of anti-self GluR3B autoantibodies, which activate and kill neurons, found in patients with various types of epilepsy.

Human B Cells Secrete Granzyme B When Recognizing Viral Antigens in the Context of the Acute Phase Cytokine IL-21

“…These potential functions may include cytokine-like functions (36,39), cleavage of surface molecules such as receptors (40,41), matrix degradation or remodeling (42), immunosuppressive functions (43,44), or direct destruction of viral proteins important for replication or assembly (reviewed in Refs. 18 and 45).…”

Peripheral leukocyte profile in people with temporal lobe epilepsy reflects the associated proinflammatory state

“…Granzyme A is a serine protease involved in several immune functions, including cell death by non-apoptotic pathways [21,24], and mediation of inflammatory cytokine release [25][26][27]. Granzyme A produced by CD8 + and NK cells could be involved in cytokine production and apoptotic response in epilepsy.…”

Death by a Thousand Cuts: Granzyme Pathways of Programmed Cell Death

“…In addition, GzmB can degrade cartilage proteoglycans potentially to exacerbate autoimmune or inflammatory arthritis (197,198). In the central nervous system, GzmB cleaves a glutamate receptor (GluR3), potentially contributing to immunoneurotoxicity, excitation, and autoimmunity in the brain (199,200). GzmB on its own causes death of neurons in a pertussis toxin-sensitive manner, suggesting possible cleavage or involvement of G protein-coupled receptors (201).…”